Skip to content

Study on the establishment of a risk prognosis model for future asthma attacks in adults combined with novel biomarkers

Study on the establishment of a risk prognosis model for future asthma attacks in adults combined with novel biomarkers

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057627
Enrollment
Unknown
Registered
2022-03-15
Start date
2022-03-12
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

None listed

Sponsors

Yubei District people's Hospital of Chongqing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Above the age of 18 years; 2. Meet the diagnostic criteria for bronchial asthma of ICD-10; 3. Non-asthmatic acute attack at the time of inclusion; 4. Have been on regular asthma medication for at least 3 months.

Exclusion criteria

Exclusion criteria: 1. Combined with chronic obstructive pulmonary disease; 2. Combined with acute infection of various sites such as lung infection; 3. A history of mental illness and senile dementia; 4. Obvious abnormal liver, kidney and thyroid function; 5. Stroke, myocardial infarction, heart failure and other major chronic diseases; 6. Pregnancy and lactation; 7. Family members or patients do not agree to participate in this study.

Design outcomes

Primary

MeasureTime frame
Future attacks of asthma;

Countries

China

Contacts

Public ContactZhang Li

Yubei District people's Hospital of Chongqing

80564361@qq.com+86 13647613465

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026